{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:34:48Z","timestamp":1789662888770,"version":"4.0.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-118167RB-I00"],"award-info":[{"award-number":["PID2020-118167RB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["201924-30"],"award-info":[{"award-number":["201924-30"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019180","name":"HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","award":["810287"],"award-info":[{"award-number":["810287"]}],"id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014139","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","doi-asserted-by":"publisher","award":["CB16\/12\/00225"],"award-info":[{"award-number":["CB16\/12\/00225"]}],"id":[{"id":"10.13039\/501100014139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014139","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","doi-asserted-by":"publisher","award":["CB16\/12\/00334"],"award-info":[{"award-number":["CB16\/12\/00334"]}],"id":[{"id":"10.13039\/501100014139","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"Ag\u00e8ncia de Gesti\u00f3 d'Ajuts Universitaris i de Recerca","doi-asserted-by":"publisher","award":["2018-BP-00231"],"award-info":[{"award-number":["2018-BP-00231"]}],"id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1053\/j.seminhematol.2023.11.005","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T07:45:52Z","timestamp":1701416752000},"page":"172-180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Biological, prognostic, and therapeutic impact of the epigenome in CLL"],"prefix":"10.1053","volume":"61","author":[{"given":"Alba","family":"Maiques-Diaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8809-5195","authenticated-orcid":false,"given":"Jose Ignacio","family":"Martin-Subero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1053\/j.seminhematol.2023.11.005_bib0001","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.3324\/haematol.2019.236000","article-title":"Chronic lymphocytic leukemia: from molecular pathogenesis to novel therapeutic strategies","volume":"105","author":"Delgado","year":"2020","journal-title":"Haematologica"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.005_bib0002","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1182\/blood-2016-06-719294","article-title":"Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia","volume":"129","author":"Ahn","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.005_bib0003","first-page":"727","article-title":"Clonal dynamics towards the development of venetoclax resistance in chronic lymphocytic leukemia","volume":"9","author":"Herling","year":"2018","journal-title":"NatCommun"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.11.005_bib0004","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/blood-2015-03-585075","article-title":"Targeted therapies in CLL: mechanisms of resistance and strategies for management","volume":"126","author":"Woyach","year":"2015","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.005_bib0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1182\/blood.2019001262","article-title":"Integrative analysis of spontaneous CLL regression highlights genetic and microenvironmental interdependency in CLL","volume":"135","author":"Kwok","year":"2020","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.005_bib0006","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.005_bib0007","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"issue":"7574","key":"10.1053\/j.seminhematol.2023.11.005_bib0008","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature14666","article-title":"Non-coding recurrent mutations in chronic lymphocytic leukaemia","volume":"526","author":"Puente","year":"2015","journal-title":"Nature"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.005_bib0009","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1038\/s41588-022-01140-w","article-title":"Molecular map of chronic lymphocytic leukemia and its impact on outcome","volume":"54","author":"Knisbacher","year":"2022","journal-title":"Nat Genet"},{"issue":"7574","key":"10.1053\/j.seminhematol.2023.11.005_bib0010","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nature15395","article-title":"Mutations driving CLL and their evolution in progression and relapse","volume":"526","author":"Landau","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.11.005_bib0011","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.cell.2007.01.033","article-title":"The mammalian epigenome","volume":"128","author":"Bernstein","year":"2007","journal-title":"Cell"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.005_bib0012","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1182\/blood-2010-07-155663","article-title":"Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities","volume":"117","author":"Chiorazzi","year":"2011","journal-title":"Blood"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.11.005_bib0013","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.hoc.2021.03.002","article-title":"Potential relevance of B-cell maturation pathways in defining the cell(s) of origin for chronic lymphocytic leukemia","volume":"35","author":"Ng","year":"2021","journal-title":"Hematol Oncol Clin North Am"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.11.005_bib0014","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1084\/jem.20120833","article-title":"Cellular origin and pathophysiology of chronic lymphocytic leukemia","volume":"209","author":"Seifert","year":"2012","journal-title":"J Exp Med"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.005_bib0015","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1084\/jem.194.11.1625","article-title":"Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells","volume":"194","author":"Klein","year":"2001","journal-title":"J Exp Med"},{"key":"10.1053\/j.seminhematol.2023.11.005_bib0016","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.devcel.2015.12.001","article-title":"Regulation of cellular identity in cancer","volume":"35","author":"Roy","year":"2015","journal-title":"Dev. Cell"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.005_bib0017","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1101\/gad.947102","article-title":"DNA methylation patterns and epigenetic memory","volume":"16","author":"Bird","year":"2002","journal-title":"Genes Dev"},{"issue":"7","key":"10.1053\/j.seminhematol.2023.11.005_bib0018","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrg3230","article-title":"Functions of DNA methylation: islands, start sites, gene bodies and beyond","volume":"13","author":"Jones","year":"2012","journal-title":"Nat Rev Genet"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.005_bib0019","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.bbagrm.2013.08.001","article-title":"Intragenic DNA methylation in transcriptional regulation, normal differentiation and cancer","volume":"1829","author":"Kulis","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1053\/j.seminhematol.2023.11.005_bib0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.semcancer.2017.08.008","article-title":"Charting the dynamic epigenome during B-cell development","volume":"51","author":"Martin-Subero","year":"2018","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"10.1053\/j.seminhematol.2023.11.005_bib0021","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/ng.3291","article-title":"Whole-genome fingerprint of the DNA methylome during human B cell differentiation","volume":"47","author":"Kulis","year":"2015","journal-title":"Nat Genet"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.005_bib0022","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/ng.2443","article-title":"Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia","volume":"44","author":"Kulis","year":"2012","journal-title":"Nat Genet"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.11.005_bib0023","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/ng.3488","article-title":"DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia","volume":"48","author":"Oakes","year":"2016","journal-title":"Nat Genet"},{"issue":"21","key":"10.1053\/j.seminhematol.2023.11.005_bib0024","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1182\/blood.2020008311","article-title":"IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics","volume":"137","author":"Nadeu","year":"2021","journal-title":"Blood"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.11.005_bib0025","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1073\/pnas.1913810117","article-title":"IGLV3-21*01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling","volume":"117","author":"Maity","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"10.1053\/j.seminhematol.2023.11.005_bib0026","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1182\/blood-2011-06-357996","article-title":"DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation","volume":"118","author":"Shaknovich","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.11.005_bib0027","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/leu.2014.252","article-title":"A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact","volume":"29","author":"Queir\u00f3s","year":"2015","journal-title":"Leukemia"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.11.005_bib0028","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1182\/blood.2019000490","article-title":"Developmental subtypes assessed by DNA methylation-iPLEX forecast the natural history of chronic lymphocytic leukemia","volume":"134","author":"Giacopelli","year":"2019","journal-title":"Blood"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.005_bib0029","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/15592294.2016.1178432","article-title":"Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: the case of subset #2","volume":"11","author":"Bhoi","year":"2016","journal-title":"Epigenetics"},{"issue":"16","key":"10.1053\/j.seminhematol.2023.11.005_bib0030","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/bloodadvances.2019000237","article-title":"Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials","volume":"3","author":"Wojdacz","year":"2019","journal-title":"Blood Adv"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.005_bib0031","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/leu.2012.245","article-title":"450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments","volume":"27","author":"Cahill","year":"2013","journal-title":"Leukemia"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.005_bib0032","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/s43018-020-00131-2","article-title":"The proliferative history shapes the DNA methylome of B-cell tumors and predicts clinical outcome","volume":"1","author":"Duran-Ferrer","year":"2020","journal-title":"Nat Cancer"},{"issue":"23","key":"10.1053\/j.seminhematol.2023.11.005_bib0033","doi-asserted-by":"crossref","first-page":"7384","DOI":"10.1182\/bloodadvances.2023010132","article-title":"IGLV3-21R110 mutation has prognostic value in patients with treatment-naive chronic lymphocytic leukemia","volume":"7","author":"Syrykh","year":"2023","journal-title":"Blood Adv"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.11.005_bib0034","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41588-018-0073-4","article-title":"DNA methylation loss in late-replicating domains is linked to mitotic cell division","volume":"50","author":"Zhou","year":"2018","journal-title":"Nat Genet"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.005_bib0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/s13059-016-1064-3","article-title":"Correlation of an epigenetic mitotic clock with cancer risk","volume":"17","author":"Yang","year":"2016","journal-title":"Genome Biol"},{"key":"10.1053\/j.seminhematol.2023.11.005_bib0036","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41576-018-0004-3","article-title":"DNA methylation-based biomarkers and the epigenetic clock theory of ageing","volume":"19","author":"Horvath","year":"2018","journal-title":"Nat Rev Genet"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.005_bib0037","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ccell.2014.10.012","article-title":"Locally disordered methylation forms the basis of intratumor methylome variation in chronic lymphocytic leukemia","volume":"26","author":"Landau","year":"2014","journal-title":"Cancer Cell"},{"issue":"7757","key":"10.1053\/j.seminhematol.2023.11.005_bib0038","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41586-019-1198-z","article-title":"Epigenetic evolution and lineage histories of chronic lymphocytic leukaemia","volume":"569","author":"Gaiti","year":"2019","journal-title":"Nature"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.005_bib0039","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41389-019-0142-2","article-title":"Ibrutinib induces chromatin reorganisation of chronic lymphocytic leukaemia cells","volume":"8","author":"Holmes","year":"2019","journal-title":"Oncogenesis"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.11.005_bib0040","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41591-022-01927-8","article-title":"Detection of early seeding of Richter transformation in chronic lymphocytic leukemia","volume":"28","author":"Nadeu","year":"2022","journal-title":"Nat Med"},{"key":"10.1053\/j.seminhematol.2023.11.005_bib0041","doi-asserted-by":"crossref","first-page":"11938","DOI":"10.1038\/ncomms11938","article-title":"Chromatin accessibility maps of chronic lymphocytic leukaemia identify subtype-specific epigenome signatures and transcription regulatory networks","volume":"7","author":"Rendeiro","year":"2016","journal-title":"Nat Commun"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.005_bib0042","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.ccell.2018.11.001","article-title":"Enhancer architecture and essential core regulatory circuitry of chronic lymphocytic leukemia","volume":"34","author":"Ott","year":"2018","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1053\/j.seminhematol.2023.11.005_bib0043","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41591-018-0028-4","article-title":"The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia","volume":"24","author":"Beekman","year":"2018","journal-title":"Nat Med"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.005_bib0044","doi-asserted-by":"crossref","first-page":"e8339","DOI":"10.15252\/msb.20188339","article-title":"Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks","volume":"15","author":"Mallm","year":"2019","journal-title":"Mol Syst Biol"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.005_bib0045","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1038\/s41467-019-09645-5","article-title":"Corrupted coordination of epigenetic modifications leads to diverging chromatin states and transcriptional heterogeneity in CLL","volume":"10","author":"Pastore","year":"2019","journal-title":"Nat Commun"},{"issue":"9","key":"10.1053\/j.seminhematol.2023.11.005_bib0046","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.3324\/haematol.2016.160374","article-title":"Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier","volume":"102","author":"Navarro","year":"2017","journal-title":"Haematologica"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.005_bib0047","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1038\/s41467-019-11582-2","article-title":"Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics","volume":"10","author":"Speedy","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.005_bib0048","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41467-019-14081-6","article-title":"Chromatin mapping and single-cell immune profiling define the temporal dynamics of ibrutinib response in CLL","volume":"11","author":"Rendeiro","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.11.005_bib0049","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s41589-018-0205-2","article-title":"Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL","volume":"15","author":"Schmidl","year":"2019","journal-title":"Nat Chem Biol"},{"issue":"21","key":"10.1053\/j.seminhematol.2023.11.005_bib0050","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1182\/blood-2014-02-548610","article-title":"Ibrutinib inhibits BCR and NF-\u03ba B signaling and reduces tumor proliferation in tissue-resident cells of patients with CLL","volume":"123","author":"Herman","year":"2014","journal-title":"Blood"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.11.005_bib0051","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41416-020-01117-8","article-title":"Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemia","volume":"124","author":"Barrow","year":"2021","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.005_bib0052","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13148-019-0783-1","article-title":"DNA methylation profiles in chronic lymphocytic leukemia patients treated with chemoimmunotherapy","volume":"11","author":"Tsagiopoulou","year":"2019","journal-title":"Clin Epigenetics"},{"issue":"8","key":"10.1053\/j.seminhematol.2023.11.005_bib0053","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/s43018-021-00216-6","article-title":"Multi-omics reveals clinically relevant proliferative drive associated with mTOR-MYC-OXPHOS activity in chronic lymphocytic leukemia","volume":"2","author":"Lu","year":"2021","journal-title":"Nat Cancer"},{"issue":"3","key":"10.1053\/j.seminhematol.2023.11.005_bib0054","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.clml.2012.11.009","article-title":"Azacitidine in fludarabine-refractory chronic lymphocytic leukemia: a phase II study","volume":"13","author":"Malik","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.11.005_bib0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.2010.08213.x","article-title":"Phase I trial of low dose decitabine targeting DNA hypermethylation in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: dose-limiting myelosuppression without evidence of DNA hypomethylation","volume":"150","author":"Blum","year":"2010","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1053\/j.seminhematol.2023.11.005_bib0056","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1158\/2159-8290.CD-17-0902","article-title":"BRD4 profiling identifies critical chronic lymphocytic leukemia oncogenic circuits and reveals sensitivity to PLX51107, a novel structurally distinct BET inhibitor","volume":"8","author":"Ozer","year":"2018","journal-title":"Cancer Discov"},{"key":"10.1053\/j.seminhematol.2023.11.005_bib0057","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cell.2013.03.036","article-title":"Selective inhibition of tumor oncogenes by disruption of super-enhancers","volume":"153","author":"Loven","year":"2013","journal-title":"Cell"},{"issue":"2","key":"10.1053\/j.seminhematol.2023.11.005_bib0058","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yexmp.2018.07.009","article-title":"EZH2 is upregulated in the proliferation centers of CLL\/SLL lymph nodes","volume":"105","author":"Szuri\u00e1n","year":"2018","journal-title":"Exp Mol Pathol"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.11.005_bib0059","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/bloodadvances.2018030262","article-title":"Inhibition of EZH2 and immune signaling exerts synergistic antitumor effects in chronic lymphocytic leukemia","volume":"3","author":"Chartomatsidou","year":"2019","journal-title":"Blood Adv"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.005_bib0060","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bcmd.2014.07.013","article-title":"Overexpression of EZH2 associates with a poor prognosis in chronic lymphocytic leukemia","volume":"54","author":"Rabello Ddo","year":"2015","journal-title":"Blood Cells Mol Dis"},{"issue":"11","key":"10.1053\/j.seminhematol.2023.11.005_bib0061","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1080\/15592294.2019.1633867","article-title":"EZH2 upregulates the PI3K\/AKT pathway through IGF1R and MYC in clinically aggressive chronic lymphocytic leukaemia","volume":"14","author":"Kosalai","year":"2019","journal-title":"Epigenetics"},{"issue":"10","key":"10.1053\/j.seminhematol.2023.11.005_bib0062","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.4161\/15592294.2014.969628","article-title":"Global histone deacetylase enzymatic activity is an independent prognostic marker associated with a shorter overall survival in chronic lymphocytic leukemia patients","volume":"9","author":"Van Damme","year":"2014","journal-title":"Epigenetics"},{"issue":"5","key":"10.1053\/j.seminhematol.2023.11.005_bib0063","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1182\/blood-2011-05-351510","article-title":"Histone deacetylases mediate the silencing of miR-15a, miR-16, and miR-29b in chronic lymphocytic leukemia","volume":"119","author":"Sampath","year":"2012","journal-title":"Blood"},{"issue":"12","key":"10.1053\/j.seminhematol.2023.11.005_bib0064","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1182\/bloodadvances.2022007998","article-title":"HDAC1 regulates the chromatin landscape to control transcriptional dependencies in chronic lymphocytic leukemia","volume":"7","author":"Lai","year":"2023","journal-title":"Blood Adv"},{"key":"10.1053\/j.seminhematol.2023.11.005_bib0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.590072","article-title":"HDAC6 inhibition alleviates CLL-induced T-cell dysfunction and enhances immune checkpoint blockade efficacy in the E\u03bc-TCL1 model","volume":"11","author":"Maharaj","year":"2020","journal-title":"Front Immunol"},{"issue":"1","key":"10.1053\/j.seminhematol.2023.11.005_bib0066","first-page":"44","article-title":"Oncogenic role and target properties of the lysine-specific demethylase KDM1A in chronic lymphocytic leukemia","volume":"142","author":"Jiang","year":"2023","journal-title":"Blood"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196323000926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196323000926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T13:19:16Z","timestamp":1720531156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196323000926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0037196323000926"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2023.11.005","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological, prognostic, and therapeutic impact of the epigenome in CLL","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2023.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}